Key result
Staged complete in-hospital revascularisation in STEMI patients did not increase serious bleeding, but increased minimal and medical attention bleedings.
Why the study?
It was unclear whether a staged in-hospital complete revascularisation strategy increases the risk of serious bleeding events in STEMI patients with multivessel disease.
Does a staged in-hospital complete revascularisation strategy increase the risk of serious bleeding events in patients with STEMI and multivessel disease?
RCT (n=627)
1:1
Does a staged in-hospital complete revascularisation strategy increase the risk of serious bleeding events in patients with STEMI and multivessel disease?
A staged complete in-hospital revascularisation strategy in STEMI patients with multivessel disease does not increase serious bleeding events, though it is associated with more minimal bleedings.
Answers are grounded in this paper and cite their sources.
Staged complete revascularisation in STEMI did not increase serious bleeding; leaves open whether excess minor bleedings affect net benefit in randomized trials.
AIMS: The aim of this study was to evaluate whether a staged in-hospital complete revascularisation strategy increases the risk of serious bleeding events in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. METHODS AND RESULTS: The DANAMI-3-PRIMULTI trial investigated whether a staged in-hospital complete revascularisation strategy improved outcome in patients with STEMI and multivessel disease. In this substudy, we investigated potential bleeding complications related to a second in-hospital procedure. Bleedings were assessed using BARC and TIMI criteria. Six hundred and twenty-seven (627) patients were randomised 1:1 to either PCI of the infarct-related artery (IRA) only (n=313) or complete revascularisation during a staged procedure before discharge (n=314). We found no significant difference in TIMI major+minor bleedings related to the primary PCI. There were neither major nor minor bleedings in relation to the second procedure in the complete revascularisation arm. There were significantly more in-hospital minimal+medical attention bleedings in the group randomised to complete revascularisation (61.5% vs. 49.5% in the IRA-PCI only group, p=0.003), but no difference in admission time or one-year mortality (2.2% complete revascularisation-group vs. 2.6% IRA-PCI only group, p=0.8). CONCLUSIONS: In multivessel diseased STEMI patients, a staged complete in-hospital revascularisation strategy or any second in-hospital procedure did not result in an increase in serious bleeding events.
No takes yet. Share an insight, caveat, or question.
Sadjadieh et al. (2016) conducted an RCT in ST-segment elevation myocardial infarction (STEMI) and multivessel disease (n=627). Staged in-hospital complete revascularisation vs. PCI of the infarct-related artery (IRA) only was evaluated on In-hospital minimal+medical attention bleedings (p=0.003). Staged complete in-hospital revascularisation in STEMI patients did not increase serious bleeding, but increased minimal and medical attention bleedings.
Synapse has enriched 10 related papers. Consider them for comparative context: